Laboratory Solutions

Bioscience Production

- Proprietary

- Third-party

Services & Specialty Procurement

Equipment & Instrumentation

Total Revenue

62fb13afec8eacacb51fd09a5e9b199cbbd871ea62b9d86628cdb6c6c0086d8c

Net sales (USD, millions)

Cost of sales (USD, millions)

Gross profit (USD, millions)

Selling, general and administrative expenses (USD, millions)

Impairment charges (USD, millions)

Gain on sale of business (USD, millions)

Operating income (USD, millions)

Interest expense, net (USD, millions)

Loss on extinguishment of debt (USD, millions)

Other (expense) income, net (USD, millions)

Income before income taxes (USD, millions)

Income tax expense (USD, millions)

Net income (USD, millions)

Accumulation of yield on preferred stock (USD, millions)

Net income available to common stockholders (USD, millions)

Earnings per share: Basic (USD)

Earnings per share: Diluted (USD)

Weighted average shares outstanding: Basic (millions)

Weighted average shares outstanding: Diluted (millions)

782a8016aae3db348abd22e5e2c29a77989a576c70ac7e3c0b07b12b652c3d20

Free cash flow (USD millions)

Organic net sales growth (decline) for Laboratory Solutions (percentage)

Organic net sales growth (decline) for Bioscience Production (percentage)

Organic net sales growth (decline) for total (percentage)

39e200b8864d296948811f262a37885b5854bdbae85735586a841dc2be1ef39f

Cash and cash equivalents (USD, millions)

Accounts receivable, net (USD, millions)

Inventory (USD, millions)

Other current assets (USD, millions)

Assets held for sale (USD, millions)

Total current assets (USD, millions)

Property, plant and equipment, net (USD, millions)

Other intangible assets, net (USD, millions)

Goodwill, net (USD, millions)

Other assets (USD, millions)

Total assets (USD, millions)

Current portion of debt (USD, millions)

Accounts payable (USD, millions)

Employee-related liabilities (USD, millions)

Accrued interest (USD, millions)

Other current liabilities (USD, millions)

Liabilities held for sale (USD, millions)

Total current liabilities (USD, millions)

Debt, net of current portion (USD, millions)

Deferred income tax liabilities (USD, millions)

Other liabilities (USD, millions)

Total liabilities (USD, millions)

Common stock including paid-in capital (USD, millions)

Accumulated earnings (USD, millions)

Accumulated other comprehensive loss (USD, millions)

Total stockholders’ equity (USD, millions)

Total liabilities and stockholders’ equity (USD, millions)

5087898cf51805a19c4b5e83440734ffb257357e172a613097032731925b53f6

Depreciation and amortization (USD, millions)

Stock-based compensation expense (USD, millions)

Non-cash restructuring charges (USD, millions)

Provision for accounts receivable and inventory (USD, millions)

Deferred income tax benefit (USD, millions)

Amortization of deferred financing costs (USD, millions)

Foreign currency remeasurement loss (gain) (USD, millions)

Pension termination charges (USD, millions)

Other - Operating activities (USD, millions)

Net cash provided by operating activities (USD, millions)

Capital expenditures (USD, millions)

Cash paid for acquisitions, net of cash acquired (USD, millions)

Cash proceeds from settlement of cross currency swap (USD, millions)

Proceeds from sale of disposal group, net of cash sold (USD, millions)

Other - Investing activities (USD, millions)

Net cash provided by (used in) investing activities (USD, millions)

Debt borrowings (USD, millions)

Debt repayments (USD, millions)

Payments of debt refinancing fees and premiums (USD, millions)

Proceeds received from exercise of stock options (USD, millions)

Shares repurchased to satisfy employee tax obligations for vested stock-based awards (USD, millions)

Net cash used in financing activities (USD, millions)

Effect of currency rate changes on cash and cash equivalents (USD, millions)

Net change in cash, cash equivalents and restricted cash (USD, millions)

Accounts receivable (USD, millions)

Other assets and liabilities (USD, millions)

Cash, cash equivalents and restricted cash, beginning of period/year (USD, millions)

Avantor Inc (AVTR)

Financials